Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:192802rdf:typepubmed:Citationlld:pubmed
pubmed-article:192802lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:192802lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:192802lifeskim:mentionsumls-concept:C0003342lld:lifeskim
pubmed-article:192802lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:192802pubmed:issue1lld:pubmed
pubmed-article:192802pubmed:dateCreated1977-6-11lld:pubmed
pubmed-article:192802pubmed:abstractTextCytolytic T lymphocytes (CTL) from murine sarcoma virus (MSV) or Friend leukaemia virus (FLV) inoculated mice lyse syngeneic much more efficiently than allogeneic FMRGi+ lymphoma cells. By comparing the cytolysis of various H-2 different 51Cr lymphomas by CTL from several inbred and congenic lines differing at H-2, and by competition experiments using unlabelled cells, one can demonstrate that this phenomenon is due to an H-2 barrier. H-2b/H-2d hybrid-anti-MSV-CTL immunized by H-2b, H-2d or H-2b/H-2d tumours lyse only FMRGi+ lymphomas of the same H-2, and their activity for a given target is inhibited only by H-2-identical competitive cells. H-2 antigens are therefore directly involved in the interaction between tumour cells and immune CTL which probably react with an 'H-2 modified' antigen of the tumour cells surface. The use of CTL from intra-H-2 recombinant lines shows that H-2D and probably H-2K molecules are involved, but vary according to the tumour cells. A possible role of the I region is discussed as well as the implications of these results in immunosurveillance against viral neoplasia.lld:pubmed
pubmed-article:192802pubmed:languageenglld:pubmed
pubmed-article:192802pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:192802pubmed:citationSubsetIMlld:pubmed
pubmed-article:192802pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:192802pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:192802pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:192802pubmed:statusMEDLINElld:pubmed
pubmed-article:192802pubmed:monthFeblld:pubmed
pubmed-article:192802pubmed:issn0305-1811lld:pubmed
pubmed-article:192802pubmed:authorpubmed-author:LevyJ PJPlld:pubmed
pubmed-article:192802pubmed:authorpubmed-author:GomardEElld:pubmed
pubmed-article:192802pubmed:authorpubmed-author:DuprezVVlld:pubmed
pubmed-article:192802pubmed:authorpubmed-author:HeninYYlld:pubmed
pubmed-article:192802pubmed:issnTypePrintlld:pubmed
pubmed-article:192802pubmed:volume4lld:pubmed
pubmed-article:192802pubmed:ownerNLMlld:pubmed
pubmed-article:192802pubmed:authorsCompleteYlld:pubmed
pubmed-article:192802pubmed:pagination35-45lld:pubmed
pubmed-article:192802pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:192802pubmed:meshHeadingpubmed-meshheading:192802-A...lld:pubmed
pubmed-article:192802pubmed:meshHeadingpubmed-meshheading:192802-M...lld:pubmed
pubmed-article:192802pubmed:meshHeadingpubmed-meshheading:192802-S...lld:pubmed
pubmed-article:192802pubmed:meshHeadingpubmed-meshheading:192802-L...lld:pubmed
pubmed-article:192802pubmed:meshHeadingpubmed-meshheading:192802-M...lld:pubmed
pubmed-article:192802pubmed:meshHeadingpubmed-meshheading:192802-T...lld:pubmed
pubmed-article:192802pubmed:meshHeadingpubmed-meshheading:192802-L...lld:pubmed
pubmed-article:192802pubmed:meshHeadingpubmed-meshheading:192802-R...lld:pubmed
pubmed-article:192802pubmed:meshHeadingpubmed-meshheading:192802-F...lld:pubmed
pubmed-article:192802pubmed:meshHeadingpubmed-meshheading:192802-M...lld:pubmed
pubmed-article:192802pubmed:meshHeadingpubmed-meshheading:192802-A...lld:pubmed
pubmed-article:192802pubmed:meshHeadingpubmed-meshheading:192802-I...lld:pubmed
pubmed-article:192802pubmed:meshHeadingpubmed-meshheading:192802-C...lld:pubmed
pubmed-article:192802pubmed:meshHeadingpubmed-meshheading:192802-A...lld:pubmed
pubmed-article:192802pubmed:meshHeadingpubmed-meshheading:192802-H...lld:pubmed
pubmed-article:192802pubmed:meshHeadingpubmed-meshheading:192802-T...lld:pubmed
pubmed-article:192802pubmed:meshHeadingpubmed-meshheading:192802-S...lld:pubmed
pubmed-article:192802pubmed:year1977lld:pubmed
pubmed-article:192802pubmed:articleTitleRelationships between H-2 and viral antigens in murine oncornavirus-induced tumours.lld:pubmed
pubmed-article:192802pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:192802pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:192802pubmed:publicationTypeIn Vitrolld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:192802lld:pubmed